Thyroid disorder decisions — 2024

The Veteran's combined disability rating is 100 percent, but he does not have a single disability rated at 100 percent. The Board finds that the Veteran's service-connected disabilities alone do not result in the need for aid and attendance.

The Board has remanded the claims of service connection for tinnitus and thyroid condition due to new evidence being associated with the file.

The Board has remanded the claims for service connection due to contaminated water at Camp Lejeune for prostate, colon, thyroid, and lung conditions. The AOJ is instructed to obtain a VA examination but must consider the Veteran's inability to attend in-person examinations.

The Board has remanded the claims for service connection due to new evidence from the PACT Act, which requires a toxic exposure risk activity (TERA) examination.

The Veteran's representative withdrew the appeal regarding his thyroid condition, and as a result, the appeal is dismissed.

The Board has decided to remand the case due to insufficient evidence regarding the relationship between the Veteran's disability and his service, particularly Agent Orange exposure. The VA is instructed to obtain a medical opinion on these issues.

The Veteran withdrew her appeals for increased ratings for Meniere's syndrome and residual scar of a status post thyroid surgery prior to September 5, 2020.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's congestive heart failure is related to his service-connected hypothyroidism. The VA will obtain an addendum opinion addressing this theory of entitlement.

The Veteran's claim for a compensable disability rating for hypothyroidism was denied as there is no evidence of myxedema or other compensable residual signs and symptoms.

The Board has withdrawn the claim for service connection for hypoparathyroidism and has remanded the issue of service connection for congestive heart failure due to a lack of development in obtaining relevant medical records.

The Board denied the appellant's request for an extension of her delimiting date for educational assistance benefits under Chapter 35 (DEA) beyond December 13, 2020, as there were no additional periods where she suspended education due to conditions beyond her control.

The Veteran's pituitary adenoma, gynecomastia, hypothyroidism, hypertension, diabetes mellitus type II (DMII), hypogonadism, and upper gastrointestinal (GI) ulcer with hemorrhaging are all granted as service-connected due to in-service exposure to ionizing radiation.

The Veteran's hypothyroidism with myxedema is currently rated under Diagnostic Code 7903-7319. The Board finds the February and March 2024 examinations inadequate as they did not address whether the Veteran was experiencing a myxedema crisis or if his condition was considered stable.

The Board denied service connection for hypothyroidism as there was no evidence of herbicide agent exposure during service and the Veteran's own assertions were not supported by medical literature.

The Board has denied service connection for migraines and remanded the claim of service connection for hypothyroidism.

The Veteran withdrew his claims for service connection for left shoulder condition and thyroid stimulating hormone level, resulting in their dismissal.

The Veteran's appeal for service connection for colon cancer due to herbicide exposure is dismissed because the March 2010 rating decision has become final. The claim of an initial disability rating greater than 10 percent for hypothyroidism is remanded.

The Veteran's claims for compensable disability ratings for allergic rhinitis, IBS with gastritis, migraine headaches, and thyroid disability have all been denied. The evidence does not meet the criteria for a compensable rating under applicable diagnostic codes.

The Veteran's claims for increased initial ratings for diabetes mellitus, type II, hypertension, and hypothyroidism are being remanded due to the failure of VA to attempt to resolve known impediments to scheduling a VA examination.

The Veteran's hypothyroidism disability was manifested by severe weight gain, sleepiness, cardiovascular involvement, muscular weakness, and depression. The Board granted a disability rating of 100 percent for the entire appeal period from April 4, 2007 to January 20, 2014.